Clinical Trial Update: MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating unrelated reduced-intensity conditioning with Treosulfan for allogeneic stem cell transplantation in patients with hematologic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Treosulfan (treosulfan)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hematological Malignancies, Allogeneic Transplantation | Phase 2 | Status: UNKNOWN